当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
T Dessain, S Tahir, D Dabrowska
Background: Single dose of intravenousdexamethasone has been shown to improve post operative analgesia in obstetric patients Our aim was to establish if a single dose of dexamethasone would improve pains cores and reduce opioid consumptionas part of multimodalanalgesic regime. Methods : Over a 6 monthperiod data wascollected for 34 patientsundergoingelective C-section. A control group received standardised CSE and intraoperativeanalgesics The intervention group received an additional single dose of intravenous 6.6mg dexamethasone (n=20). Post operatively patients received standardised analgesia and were reviewed the followingday. Primary out comes were post operative opioid consumption and subjectivepain score using VAS. Results: Patients receiving dexamethas one showed significantly lower pain scores on the first postoperative day ((median (IQR) − 2.5 (1 - 4)) compared to the control group (median (IQR) - 6 (5 - 7)), p=0.001 with no side-effects. Therewas no benefit of dexamethasone on the averagehourlyopioidconsumption ((median (IQR) − 1.125mg/hr (0 - 1.8mg/hr)) compared to the control group ((median (IQR) - 0.65mg/hr (0 - 1.25mg/hr)), p=0.516. Conclusions: IV Dexamethasoneis a safe non-opiate adjunctwhichreducedpostoperativepainscores and shouldconsideredduring C-sections.